Advancing mental health through precision medicine: an interview with Delphine Charvin

In a recent interview with Inside Precision Medicine, Delphine Charvin, discusses her journey as a neuroscientist and entrepreneur, and how Elkedonia is developing a non-addictive, non-hallucinogenic antidepressant targeting the Elk-1 protein.